Package 70720-101-02

{"route": ["ORAL"], "spl_id": "5de36f8a-cbc2-4884-8fcf-e9302d41c2f8", "openfda": {"upc": ["0370720101029"], "unii": ["57O5S1QSAQ"], "rxcui": ["1665503", "1673373"], "spl_set_id": ["a52896cd-4a98-49b8-82db-bf1985a64d97"], "manufacturer_name": ["TerSera Therapeutics LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TABLET in 1 BLISTER PACK (70720-101-02)", "package_ndc": "70720-101-02", "marketing_start_date": "20190806"}], "brand_name": "Varubi", "product_id": "70720-101_5de36f8a-cbc2-4884-8fcf-e9302d41c2f8", "dosage_form": "TABLET", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "70720-101", "generic_name": "rolapitant", "labeler_name": "TerSera Therapeutics LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Varubi", "active_ingredients": [{"name": "ROLAPITANT HYDROCHLORIDE", "strength": "90 mg/1"}], "application_number": "NDA206500", "marketing_category": "NDA", "marketing_start_date": "20151007", "listing_expiration_date": "20261231"}